Antolino, L.; Nucci, G.d.; Scarpino, S.; Bianco, G.; Lopez, G.; Aurello, P.; Petrucciani, N.; Santoro, R.; Nigri, G.; Agnes, S.;
et al. Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort. Onco 2025, 5, 44.
https://doi.org/10.3390/onco5040044
AMA Style
Antolino L, Nucci Gd, Scarpino S, Bianco G, Lopez G, Aurello P, Petrucciani N, Santoro R, Nigri G, Agnes S,
et al. Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort. Onco. 2025; 5(4):44.
https://doi.org/10.3390/onco5040044
Chicago/Turabian Style
Antolino, Laura, Germana de Nucci, Stefania Scarpino, Giuseppe Bianco, Gianluca Lopez, Paolo Aurello, Niccolò Petrucciani, Roberto Santoro, Giuseppe Nigri, Salvatore Agnes,
and et al. 2025. "Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort" Onco 5, no. 4: 44.
https://doi.org/10.3390/onco5040044
APA Style
Antolino, L., Nucci, G. d., Scarpino, S., Bianco, G., Lopez, G., Aurello, P., Petrucciani, N., Santoro, R., Nigri, G., Agnes, S., Manes, G., & D’Angelo, F. A.
(2025). Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort. Onco, 5(4), 44.
https://doi.org/10.3390/onco5040044